HTRF(®): pioneering technology for high-throughput screening.
Cisbio international pioneered the field of homogeneous fluorescence methodologies and time-resolved fluorescence resonance in particular, through its proprietary technology, HTRF(®). The development was based on Prof. Jean-Marie Lehn's research on rare earth fluorescence properties (awarded the Nobel Prize in Chemistry in 1987) and on Cisbio's expertise in homogenous time-resolved fluorescence (HTRF). The technology is used in assay development and drug screening, most notably in high-throughput screening applications. This highly powerful technology is particularly applied to the areas of G-protein-coupled receptor and kinase screening, as well as a series of targets related to inflammation, metabolic diseases and CNS disorders.